Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jul 2026 and Aug 2026.
- Largest single sale: $2.3M (90,616 shares) of Immunome Inc. on Aug 4, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunome Inc. (IMNM) | Chief Business Officer | Feb 21, 2024 | Aug 6, 2026 |
| Olema Pharmaceuticals, Inc. (OLMA) | Former Chief Business Officer | Nov 18, 2020 | Feb 2, 2023 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 4, 2026, Immunome Inc.: sold 90,616 shares for $2.3M, under a disclosed plan; 90,616 shares acquired by exercising options. 1 filing: 1
- Jul 23, 2026, Immunome Inc.: 31,250 shares granted. 1 filing: 1
- Jul 7, 2026, Immunome Inc.: sold 1,092 shares for $27K, under a disclosed plan; 1,092 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.